Metaphore Biotechnologies
PrivateLast Round
Early Funding
Apr 5, 2026
Total Funding Raised
$50M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Metaphore Biotechnologies is a biotechnology company that utilizes its proprietary MIMIC™ platform to design functional antibodies and therapeutic molecules based on biological dynamics and biomimicry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metaphore Biotechnologies Comparables
Compare Metaphore Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla Bio | 84% | |
| Valo Health | 78% | |
| Generate Biomedicines | 77% |
Metaphore Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 5, 2026 | ||||
| Series A | May 16, 2023 |
Metaphore Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Brain Corporation | Early Funding |
| Flagship Pioneering | Early Funding, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Raised capital from Flagship Pioneering and Novo Nordisk.
- Oct 15, 2025
$600M collaboration to develop obesity therapeutics.
Recent news
Latest coverage and updates
- is_developingJul 14, 2026
Metaphorebio is developing antibody therapeutics for metabolic disease, immunology and other high-value disease areas on Jul 1st '21.
Metaphore Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Metaphore Biotechnologies's valuation, stock price, and market status.
Is Metaphore a public or private company?
Metaphore is a private company.
What is the current stock price of Metaphore?
Metaphore is a private company with no public stock price. No recent secondary market data is available.
How much is Metaphore worth (valuation)?
Valuation information for Metaphore is not publicly available.
Can I buy Metaphore stock?
Metaphore shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Metaphore's last funding round?
Metaphore's most recent funding round was Seed on May 16, 2023.
Who are the main investors in Metaphore?
Key investors in Metaphore include Flagship Pioneering.
Will Metaphore IPO soon?
No public IPO plans have been announced for Metaphore.
How can I track Metaphore secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Metaphore's secondary market activity and sign up for updates.